Chemed (CHE) – Investment Analysts’ Recent Ratings Updates

Chemed (NYSE: CHE) has recently received a number of price target changes and ratings updates:

  • 10/29/2026 – Chemed had its price target raised by Royal Bank Of Canada from $548.00 to $585.00. They now have a “sector perform” rating on the stock.
  • 10/29/2026 – Chemed had its price target raised by UBS Group from $650.00 to $675.00. They now have a “buy” rating on the stock.
  • 10/29/2026 – Chemed had its price target raised by Oppenheimer from $590.00 to $625.00. They now have an “outperform” rating on the stock.
  • 10/28/2026 – Chemed was upgraded by Jefferies Financial Group from “hold” to “buy”. They now have a $620.00 price target on the stock, up from $520.00.
  • 10/10/2026 – Chemed was upgraded by Wall Street Zen from “buy” to “strong-buy”.
  • 10/8/2026 – Chemed was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
  • 9/25/2026 – Chemed is now covered by UBS Group. They set a “buy” rating and a $650.00 price target on the stock.
  • 9/25/2026 – Chemed is now covered by UBS Group. They set a “buy” rating and a $650.00 price target on the stock.
  • 9/25/2026 – Chemed is now covered by UBS Group. They set a “buy” rating and a $650.00 price target on the stock.
  • 9/19/2026 – Chemed was downgraded by Wall Street Zen from “strong-buy” to “buy”.

Chemed Stock Performance

Chemed stock opened at $549.36 on Monday. The company’s 50-day moving average price is $516.95 and its 200-day moving average price is $467.59. The company has a quick ratio of 1.08, a current ratio of 1.11 and a debt-to-equity ratio of 0.27. The company has a market cap of $7.15 billion, a PE ratio of 26.28, a price-to-earnings-growth ratio of 2.08 and a beta of 0.50. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.24.

Chemed (NYSE:CHE – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $6.75 EPS for the quarter, beating analysts’ consensus estimates of $6.44 by $0.31. Chemed had a net margin of 10.61% and a return on equity of 35.18%. The firm had revenue of $690.94 million during the quarter, compared to the consensus estimate of $685.04 million. During the same quarter last year, the firm earned $5.27 EPS. The firm’s revenue for the quarter was up 10.6% compared to the same quarter last year. On average, equities research analysts forecast that Chemed Corporation will post 24.05 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Monday, November 16th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. Chemed’s payout ratio is presently 13.40%.

Insider Activity at Chemed

In other Chemed news, CEO Kevin McNamara sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 3rd. The stock was sold at an average price of $537.90, for a total transaction of $1,075,800.00. Following the sale, the chief executive officer directly owned 82,220 shares in the company, valued at $44,226,138. This represents a 2.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Spencer Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $547.61, for a total value of $547,610.00. Following the completion of the sale, the executive vice president directly owned 12,931 shares of the company’s stock, valued at $7,081,144.91. The trade was a 7.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 10,920 shares of company stock worth $5,770,666 over the last three months. 3.33% of the stock is currently owned by insiders.

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.

Read More

Receive News & Ratings for Chemed Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corporation and related companies with MarketBeat.com's FREE daily email newsletter.